Parkinson’s Disease Drug Development Since 1999: A Story of Repurposing and Relative Success

BACKGROUND: A global overview of drug development programs in Parkinson’s disease over the last few decades is lacking, while such programs are challenging given the multifaceted and heterogeneous nature of the disease. OBJECTIVE: To indirectly assess drug development programs in Parkinson’s disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Boucherie, Deirdre M., Duarte, Gonçalo S., Machado, Tiago, Faustino, Patrícia R., Sampaio, Cristina, Rascol, Olivier, Ferreira, Joaquim J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150606/
https://www.ncbi.nlm.nih.gov/pubmed/33459662
http://dx.doi.org/10.3233/JPD-202184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150606/
https://www.ncbi.nlm.nih.gov/pubmed/33459662
http://dx.doi.org/10.3233/JPD-202184

Ejemplares similares